Male breast cancer: clinical-epidemiological characteristics of 1189 Brazilian patients

References

• White J, Kearins O, Dodwell D, et al. Male breast carcinoma: increased awareness needed. Breast Cancer Res 2011;13:219
   Google Scholar
• Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. Cancer J Clin 2011;61:212–36
   PubMed Web of Science ®Google Scholar
• Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993;53:538–49
   PubMed Web of Science ®Google Scholar
• Ministério da Saúde, Departamento de Informática do SUS (DATASUS) Sistema de Informação de Mortalidade. Available from: http://www.datasus.gov.br [last accessed 27 April 2013]
   Google Scholar
• Mirra AP. Incidência de câncer no Município de São Paulo, Brasil, 1983-1988-1993. Tendência no período 1969-1993. São Paulo: Registro de Câncer de São Paulo; 1998
   Google Scholar
• Instituto Nacional de Câncer (INCA); Ministério da Saúde. Câncer no Brasil: dados dos registros de base populacional. Vol 3. Rio de Janeiro (Brasil): INCA; 2003
   Google Scholar
• Instituto Nacional de Câncer (INCA); Ministério da Saúde. Câncer no Brasil – Registros de base populacional. Avalilable from: http://www.inca.gov.br/cancernobrasil/2010/docs/SaoPaulo/P437-440.pdf [last accessed 20 April 2012]
   Google Scholar
• Michels FAS, Simon A, Sconza IAC, et al. Câncer em São Paulo 1997-2008. Incidência, Mortalidade e Tendência de Câncer no Município de São Paulo. São Paulo: S.P. – Registro de Câncer de São Paulo; 2011
   Google Scholar
• Shaaban AM, Ball GR, Brannan RA, et al. A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Res Treat 2012;133:949–58
   PubMed Web of Science ®Google Scholar
• Agrawal A, Ayantunde AA, Rampaul R, Robertson JF. Male breast cancer: a review of clinical management. Breast Cancer Res Treat 2007;103:11–21
   PubMedGoogle Scholar
• Contractor KB, Kaur K, Rodrigues GS, et al. Male breast cancer: is the scenario changing. World J Surg Oncol 2008;6:58
   PubMed Web of Science ®Google Scholar
• Cunningham J, Hankey B, Lyles B, et al. The SEER program code manual. Revised edition, June 1992. Bethesda, MD: National Cancer Institute; 1992
   Google Scholar
• Brinton LA, Richesson DA, Gierach GL, et al. Prospective evaluation of risk factors for male breast cancer. Natl Cancer Inst 2008;100:1477–81
   Google Scholar
• Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol 2010;28:232–9
   PubMed Web of Science ®Google Scholar
• Gnerlich JL, Deshpande AD, Jeffe DB, et al. Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration. Ann Surg Oncol 2011;18:1837–44
   Google Scholar
• Reis LO, Dias FGF, Castro MAS, Ferreira U. Male breast cancer. Aging Male 2011;14:99–109
   Web of Science ®Google Scholar
• Nahleh ZA, Srikantiah R, Safa M, et al. Male breast cancer in the veterans affairs population: a comparative analysis. Cancer 2007;109:1471–7
   PubMed Web of Science ®Google Scholar
• Yoney A, Kucuk A, Alan A, Unsal M. Male breast cancer: a retrospective analysis. Cancer Radiother 2009;13:103–7
   Google Scholar
• Ndom P, Um G, Bell EM, et al. A meta-analysis of male breast cancer in Africa. Breast 2012;21:237–41
   PubMedGoogle Scholar
• Ahmed A, Ukwenya Y, Abdullahi A, Muhammad I. Management and outcomes of male breast cancer in Zaria, Nigeria. Int J Breast Cancer 2012;2012:845143
   Google Scholar
• Korde LA, Zujewski JA, Kamin L, et al. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol 2010;28:2114–22
   PubMed Web of Science ®Google Scholar
• Bouchardy C, Rapiti E, Fioretta G, et al. Impact of family history of breast cancer on tumour characteristics, treatment, risk of second cancer and survival among men with breast cancer. Swiss Med Wkly 2013;143:w13879
   Google Scholar
• Guerra MR, Mendonça GAS, Bustamante-Teixeira MT, et al. Five-year survival and prognostic factors in a cohort of breast cancer patients treated in Juiz de Fora, Minas Gerais State, Brazil. Cadernos de Saúde Pública 2009;25:2455–66
   Google Scholar
• Bourhafour M, Belbaraka R, Souadka A, et al. Male breast cancer: a report of 127 cases at a Moroccan institution. BMC Res Notes 2011;4:219
   PubMedGoogle Scholar
• de Ieso PB, Potter AE, Le H, et al. Male breast cancer: a 30-year experience in South Australia. Asia Pac J Clin Oncol 2012;8:187–93
   Google Scholar
• Kowalski C, Steffen P, Ernstmann N, et al. Health-related quality of life in male breast cancer patients. Breast Cancer Res Treat 2012;133:753–7
   Google Scholar
• Foerster R, Foerster FG, Wulff V, et al. Matched-pair analysis of patients with female and male breast cancer: a comparative analysis. BMC Cancer 2011;4;11:335
   Google Scholar
• Xu S, Yang Y, Tao W, et al. Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer. Breast Cancer Res Treat 2012;136:495–502
   Google Scholar
• Liu T, Tong Z, He L, Zhang L. Clinicopathological characteristics and survival analysis of 87 male breast cancer cases. Breast Care (Basel) 2011;6:446–51
   Google Scholar
• Fogh S, Hirsch AE, Langmead JP, et al. Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer. Clin Breast Cancer 2011;11:39–45
   PubMed Web of Science ®Google Scholar
• Anderson WF, Althuis MD, Brinton LA, Devesa SS. Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 2004;83:77–86
   PubMed Web of Science ®Google Scholar
• Pemmaraju N, Munsell MF, Hortobagyi GN, Giordano SH. Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects. Ann Oncol 2012;23:1471–4
   PubMed Web of Science ®Google Scholar
• Visram H, Kanji F, Dent SF. Endocrine therapy for male breast cancer: rates of toxicity and adherence. Curr Oncol 2010;17:17–21
   PubMed Web of Science ®Google Scholar